Filters

See more specimen types...

Other countries

Results: 1 to 12 of 12

Tests names and labsConditionsGenes and analytesMethods

Trimethylaminuria

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

TruGenome Predisposition Screen (Whole Genome Sequencing)

Illumina Clinical Services Laboratory Illumina
United States
15391578
  • C Sequence analysis of the entire coding region

FMO3. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

Trimethylaminuria via the FMO3 Gene

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Trimethylaminuria

Bioarray
Spain
11
  • C Sequence analysis of the entire coding region

Trimethylaminuria (sequence analysis of FMO3 gene)

CGC Genetics
Portugal
11
  • C Sequence analysis of the entire coding region

FMO3

Division Human Genetics Medical University Innsbruck
Austria
11
  • S Mutation scanning of the entire coding region

Trimethylaminuria (Fish Odor Syndrome)

Laboratory of Human Genetics Health Care Center GENOMED
Poland
11
  • C Sequence analysis of the entire coding region

FMO3

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Trimethylaminuria (TMAU): FMO3 gene full sequencing

DLE - Diagnosticos Laboratoriais Especializados
Brazil
11
  • C Sequence analysis of the entire coding region

Trimethylaminuria: FMO3 gene mutation analysis (R51G)

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
11
  • X Mutation scanning of select exons

Trimethylaminuria: FMO3 gene sequence analysis

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
11
  • C Sequence analysis of the entire coding region

Results: 1 to 12 of 12

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.